icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
Interferon-Free Regimens of Ombitasvir and ABT-450/r With or Without Ribavirin in Patients With HCV Genotype 4 Infection: PEARL-I Study Results
 
 
  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
 
Stanislas Pol1, K Rajender Reddy2, Christophe Hezode3, Tarek Hassanein4, Patrick Marcellin5, Marina Berenguer6, Katarzyna Fleischer-Stepniewska7, Niloufar Mobashery8, Coleen Hall8, Christi ne Collins8, Regis A Vilchez8 1Groupe Hospitalier Cochin-Saint Vincent De Paul, Paris, France; 2University of Pennsylvania, Philadelphia, Pennsylvania, United States; 3Hôpital Henri Mondor, Créteil, France; 4Southern California Liver Centers and Southern California Research Center, Coronado, California, United States; 5Hopital Beaujon Inserm Crb3 - U773 - Service Hepatologie, Clichy, France; 6Hospital Universitario La Fe & CIBERehd, Valencia, Spain; 7Wroclaw Medical University, Wroclaw, Poland; 8AbbVie Inc., North Chicago, Illinois, United States

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif